Veracyte partners with J&J on development of lung cancer test
The deal, with J&J Innovation and the drugmaker's lung cancer initiative, includes a $5 million upfront payment and up to $15 million in milestones.
Veracyte nabs $45M from Visium Healthcare Partners to further grow molecular diagnostics business
The next step for the company is to focus on its Percepta Bronchial Genomic Classifier - this was picked up back in 2014 when it brought in $21 million in a deal with Allegro Diagnostics. This test allows doctors to look at 23 genes in cells lining the respiratory tract to better diagnose lung cancer.
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.